PHARMAESSENTIA CORP.
Area: Pharmaceutical and Medical Devices
Booth No:
M110
Website: https://hq.pharmaessentia.com/tw
Exhibitor Profile
PharmaEssentia's novel product, Ropeginterferon alfa-2b, is granted the marketing authorization for the treatment of Polycythemia Vera (PV) by EMA, Taiwan, Korea, US, Japan, Singapore, Malaysia, China, Brazil, Argentina and Hong Kong. Additionally, Ropeginterferon alfa-2b for the treatment of Essential Thrombocythemia (ET) is also approved by Taiwan TFDA in May, 2026.
Brands
Ropeginterferon alfa-2b
Video
Exhibit Products
Exhibitors you may be interested in
Highest Rated
-
WCC BIOMEDICAL CO., LTD.
-
MINOGA INDUSTRIAL CO., LTD.
-
THERMO FISHER SCIENTIFIC
-
CREATIVE LIFE SCIENCE CO., LTD.
-
CHINA MEDICAL UNIVERSITY
-
NATIONAL HEALTH RESEARCH INSTITUTES
-
LEADGENE BIOMEDICAL, INC.
-
NANKANG BIOTECH INCUBATION CENTER
-
LEVEL BIOTECHNOLOGY INC.
-
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
-
MYCOMAGIC BIOTECHNOLOGY CO., LTD.
-
PSC BIOTECH CORPORATION
-
NATIONAL INSTITUTES OF APPLIED RESEARCH NATIONAL CENTER FOR BIOMODELS
-
MODERNA TAIWAN
-
HONG SHENG PRECISION BIOTECH CO., LTD.
-
LEVITRONIX GMBH TAIWAN BRANCH
-
INDONESIAN ECONOMIC AND TRADE OFFICE TO TAIPEI
-
GENEFERM BIOTECHNOLOGY CO., LTD.
-
BIO-TREND BIOPRODUCTS CO., LTD.
-
NATIONAL TAIWAN UNIVERSITY
-
TAIPEI MEDICAL UNIVERSITY
-
GETINGE GROUP TAIWAN CO., LTD.
-
INNOVATION HEADQUARTERS, NATIONAL CHENG KUNG UNIVERSITY (IHQ NCKU)
-
NCHU SCIENTIFIC RESEARCH PLATFORM FOR INDUSTRIALIZATION
-
NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY
-
MINISTRY OF HEALTH AND WELFARE
-
CENTRAL TAIWAN SCIENCE PARK BUREAU, NATIONAL SCIENCE AND TECHNOLOGY COUNCIL
-
SOUTHERN TAIWAN SCIENCE PARK BUREAU, NATIONAL SCIENCE AND TECHNOLOGY COUNCIL
-
HSINCHU SCIENCE PARK BUREAU, NATIONAL SCIENCE AND TECHNOLOGY COUNCIL
-
PHARMAESSENTIA CORP.
back